ERS International Congress, Milan 2017

Browse by day: Saturday, 09.09.2017 Sunday, 10.09.2017 Monday, 11.09.2017 Tuesday, 12.09.2017 Wednesday, 13.09.2017		Sponsored symposia: Industry Evening Symposium at ERS 2017: “Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics”

Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.

Oral Presentation
Chairs: R. Gosens (Groningen, Netherlands), I. Adcock (London, United Kingdom)

Late Breaking Abstract - Bacterial Load and Inflammation in Sputum from patients with Alpha-1-Antitrypsin Deficiency as compared with COPD Patients C. Sangiorgi (CASTELLANA SICULA, Italy)
COPD exacerbations significantly impact quality of life as measured by SGRQ-C total score: results from the FLAME study N. Roche (Paris, France)
Fenspiride efficacy in the treatment of chronic obstructive pulmonary disease V. Calancea (Chisinau, Republic of Moldova)
Impact of the state of endothelium on clinical and functional parameters in COPD patients with arterial hypertension. O. Titova (ST PETERSBURG, Russian Federation)
The TLR5 agonist flagellin prevents bacteria-induced chronic obstructive pulmonary disease exacerbations in mice. P. Gosset (LILLE, France)
EP2 & EP4 receptor agonists inhibit the airway sensory nerves that cause cough, a potential protective control that is lost in human smokers and a pre-clinical COPD model M. Wortley (London, United Kingdom)
Gene signatures from U-BIOPRED transcriptomic-associated clusters exist in COPD S. Pavlidis (London, United Kingdom)
Cell Therapy in Patients with Advanced Chronic Obstructive Pulmonary Disease: 3 and 6 months follow up of Six Minute Walk Test, Quality of life and Pulmonary Function E. Fiss (Sao Paulo/Sp, Brazil)